VRExplosion

VRExplosion

ICO Ended
9,797 Views
World’s First Decentralized Platform Joining Virtual Reality and Neurocomputer Interface with Blockchain Technology.
5.2
TOTAL SCORE
7.3
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Bounty: Bounty
ICO Time: 15 Nov 2018 - 15 Jan 2019
Country: Hong Kong
Token info
Ticker: VRE
Platform: Ethereum
Token Type: ERC20
Available for sale: 60,000,000 VRE (60%)
Financial
ICO Price: 1 VRE = 0.2 USD
Accepting: ETH, BTC, LTC, USD
Soft cap: 1000000 USD
Hard cap: 12000000 USD
2007
Early fundamental studies to create methods for integrating brain signals of<br /> <br /> healthy and sick person with a computer to provide non-verbal<br /> <br /> communication.<br /> <br /> Development and testing neural network method for analyzing and<br /> <br /> interpreting EEG signals for brain-computer systems. Development of a<br /> <br /> neural interface prototype.
2008 - 2009
Study and comparative analysis of electrographic patterns and mechanisms<br /> <br /> for forming voluntary motor and mental activity.<br /> <br /> Patent acquisition.
2010 - 2011
A neural networks committee to classify the electroencephalogram of mental<br /> <br /> movements forthe brain-computerinterface. Certificate of state registration<br /> <br /> for software.
2012 - 2013
Research into the influence of personality individual-typologicalfeatures on<br /> <br /> the effectiveness of self-regulation with EEG-based neurofeedback.
2012 - 2014
Experimental testing of the developed neural network methods of EEG<br /> <br /> analysis for disabled people to control a wheelchair.
2014 - 2016
Research and modeling of neuro- and psychophysiological mechanisms of<br /> <br /> the functional state ofthe brain, active perception and hierarchy of cognitive<br /> <br /> processes that provide adaptive behavior.
2014- 2015
Development and testing of visual feedback software interface based on EEG<br /> <br /> spectral characteristics of mental commands for screen interface control.<br /> <br /> Certificate of state registration for software.
2016
Development of the VRE hardware-software system (mobile biopotential<br /> <br /> amplifier) to control wireless devices (a smartphone, a tablet).<br /> <br /> Certificate of state registration for software.
2017
Development of hardware and software systems to use a neural interface in<br /> <br /> a virtual reality environment and to control a wheelchair.
2017
Study of mechanisms of multistable brain activity, sensory perception and<br /> <br /> cognitive processes to develop effective monitoring, communication and<br /> <br /> control neurotechnologies.
2018- 2019
Future research and projects:<br /> <br /> • Industrial design of a full-scale working prototype of the neurointerface.<br /> <br /> • Smart headphones.<br /> <br /> • Sleep monitoring systems.<br /> <br /> • Proprietary neural control systems for VR.
Screenshots taken on 13 Jan 2019
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Universal Recognition Token
Universal Recognition Token is the first blockchain-based corporate rewards marketplace where employees may sell and auction their gifts, rewards and prizes to the general public. URT is disrupting a $90 billion dollar annual spend market in the United States alone, according to the Incentive Federation.
Upcoming
Constellation
The Constellation protocol implements a horizontally scalable blockchain architecture known as Extended Trust Chain with a peer to peer layer known as a gossip protocol that can be deployed on a mobile device. Constellation approaches smart contracts with a microservice architecture allowing for highly available services to be chained and composed into distributed applications with just an understanding of each microservice’s SLA (service level agreement) and/or type signature. This architecture ensures high transaction throughput, allowing for consumer grade distributed applications to be built on Constellation.
Upcoming
Beyond Seen Screen
Beyond Seen Screen has created a platform that enables interactivity with video content. With Beyond Seen Screen watching video content is no longer a passive action, a one-way street. The platform enables content producers and content distribution companies to link additional information to the video content. Viewers will no longer only passively receive adverts, trailers and other video content but will have ability to interactively engage with them by using their mobile device.
Upcoming
DINNGO
The first exchange to enable simple two step verification with mobile device and cold wallet. Dinngo is revolutionising the way we trade digital currencies. Our cold wallet integrates seamlessly with the Dinngo exchange, providing the secure, fast and convenient asset trading service the market needs.
Upcoming
Orion Protocol
ORION is a new kind of blockchain investment platform that combines the best features of exchanges, brokerages, and instant trading apps. The platform is built around a liquidity aggregator connected to all of the major crypto exchanges, as well as its own internal decentralized exchange, enabling users to gain the best price for their trades from a single portal. Along with powerful tools for portfolio management, ORION offers exceptional security, convenience, and flexibility. The platform is suitable for experienced traders, institutional investors, and newcomers alike.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.